KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Amortizatization of Intangibles (2023 - 2025)

Historic Amortizatization of Intangibles for Biogen (BIIB) over the last 3 years, with Q4 2025 value amounting to $75.4 million.

  • Biogen's Amortizatization of Intangibles rose 6792.87% to $75.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $240.8 million, marking a year-over-year increase of 469.57%. This contributed to the annual value of $240.8 million for FY2025, which is 469.57% up from last year.
  • Per Biogen's latest filing, its Amortizatization of Intangibles stood at $75.4 million for Q4 2025, which was up 6792.87% from $61.5 million recorded in Q3 2025.
  • In the past 5 years, Biogen's Amortizatization of Intangibles ranged from a high of $90.1 million in Q2 2024 and a low of $31.5 million during Q4 2023
  • For the 3-year period, Biogen's Amortizatization of Intangibles averaged around $55.8 million, with its median value being $51.4 million (2025).
  • Within the past 5 years, the most significant YoY rise in Biogen's Amortizatization of Intangibles was 6792.87% (2025), while the steepest drop was 4173.14% (2025).
  • Quarter analysis of 3 years shows Biogen's Amortizatization of Intangibles stood at $31.5 million in 2023, then surged by 42.54% to $44.9 million in 2024, then skyrocketed by 67.93% to $75.4 million in 2025.
  • Its last three reported values are $75.4 million in Q4 2025, $61.5 million for Q3 2025, and $52.5 million during Q2 2025.